Delivery Order SPE2DB24D1007-SPE2DB25FB5TP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,401.39 by the Defense Logistics Agency (DLA) on August 8, 2025. The contract, designated as 4569035711, covers the supply of PREVNAR 20 vaccine in 0.5 milliliter syringes, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 8, 2025, valued at $21,820.23 for the supply of PREVNAR 20 vaccine in 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of May 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a relatively small transaction within...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on April 22, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, valued at $10,289.11, is scheduled for completion by April 23, 2025, and represents a non-set-aside, competitively awarded contract. The award was executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of PREVNAR 20 syringe vaccines (0.5mL) valued at $30,403.64. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,675.40 by the Defense Logistics Agency on August 15, 2025, for the supply of Prevnar 20 vaccine in 0.5 mL syringe format. This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, with no set-aside designation applied. The award represents a competitively-bid delivery order executed under the company's existing contract vehicle with DLA, reflecting the agency's continued reliance on...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,299.25 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of PREVNAR 20 Syringe 0.5ML, a pneumococcal vaccine product. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award is...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on April 22, 2025, for the supply of Prevnar 20 vaccine in 0.5ml syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $4,083.63 with a firm fixed price structure and an ultimate completion date of April 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Prevnar 20 Syringe 0.5ML vaccines. This competitively awarded, firm fixed-price delivery order has a ceiling value of $73,941.30 and an ultimate completion date of July 23, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency (DLA) for the supply of Prevnar 20 vaccines in 0.5mL syringes. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award was executed on August 28, 2025, with an ultimate completion date of August 29, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FB5TPDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for PREVNAR 20 Syringe 0.5ML with a ceiling value of $7,179.67. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 29, 2025. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company holds a significant competitive position in federal medical procurement, with its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This PREVNAR 20 award demonstrates the company's ongoing role in supplying essential vaccines to support military healthcare programs, reflecting DLA's reliance on AmerisourceBergen as a primary pharmaceutical supplier across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/26/25 |